RU99100578A - METHOD FOR TREATING EYE DISEASES - Google Patents
METHOD FOR TREATING EYE DISEASESInfo
- Publication number
- RU99100578A RU99100578A RU99100578/14A RU99100578A RU99100578A RU 99100578 A RU99100578 A RU 99100578A RU 99100578/14 A RU99100578/14 A RU 99100578/14A RU 99100578 A RU99100578 A RU 99100578A RU 99100578 A RU99100578 A RU 99100578A
- Authority
- RU
- Russia
- Prior art keywords
- eye diseases
- treating eye
- laser
- days
- diseases according
- Prior art date
Links
- 208000009745 Eye Disease Diseases 0.000 title claims 5
- GDPHPXYFLPDZGH-XBTMSFKCSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 GDPHPXYFLPDZGH-XBTMSFKCSA-N 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- 230000015271 coagulation Effects 0.000 claims 3
- 238000005345 coagulation Methods 0.000 claims 3
- 238000002651 drug therapy Methods 0.000 claims 2
- 230000000638 stimulation Effects 0.000 claims 2
- 210000000795 Conjunctiva Anatomy 0.000 claims 1
- 210000001328 Optic Nerve Anatomy 0.000 claims 1
- 210000001525 Retina Anatomy 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000004380 optic nerve Effects 0.000 claims 1
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU99100578A RU2198641C2 (en) | 1999-01-10 | 1999-01-10 | Method for treating ophthalmic diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU99100578A RU2198641C2 (en) | 1999-01-10 | 1999-01-10 | Method for treating ophthalmic diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99100578A true RU99100578A (en) | 2000-11-27 |
RU2198641C2 RU2198641C2 (en) | 2003-02-20 |
Family
ID=20214581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99100578A RU2198641C2 (en) | 1999-01-10 | 1999-01-10 | Method for treating ophthalmic diseases |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2198641C2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2413528C2 (en) | 2007-01-18 | 2011-03-10 | Открытое Акционерное Общество "Валента Фармацевтика" | Exenatide and dalargin drug for treating diabetes, adminisration and therapy |
EA038010B1 (en) * | 2020-01-20 | 2021-06-22 | Ооо "Промомед Рус" | Stable succinic acid hexapeptide salts |
WO2021211006A1 (en) | 2020-04-13 | 2021-10-21 | Federal State Budgetary Institution Center Of Biomedical Technologies Of Federal Medical And Biological Agency | Inhaled hexapeptide for treating interleukin-6 related respiratory diseases |
-
1999
- 1999-01-10 RU RU99100578A patent/RU2198641C2/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2204879T5 (en) | NEUROPROTECTOR FOR THE EYE OF MAMMALS THROUGH ADMINISTRATION OF BLOCKERS OF THE POTASSIUM CHANNEL. | |
EP2663281B1 (en) | Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions | |
CA2427655A1 (en) | Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization | |
JP2002534387A (en) | Use of (2-imidazolin-2-ylamino) quinoxaline for the treatment of nerve damage | |
CA2584879A1 (en) | Presbyopia treatment by lens alteration | |
WO2005030221A1 (en) | Therapeutic agent for ageing macular degeneration | |
JP5913606B2 (en) | Improved cross-linking composition effective for the treatment of keratoconus and introduced by iontophoresis | |
JPH0723325B2 (en) | Ophthalmic formulation | |
JPH08511024A (en) | Methods and compositions for reducing intraocular pressure | |
RU99100578A (en) | METHOD FOR TREATING EYE DISEASES | |
ES2234428B1 (en) | COMPOUNDS FOR THE TREATMENT OF THE DROUGHT OF THE OCULAR SURFACE CAUSED BY THE PHOTO-REFRECTIVE SURGERY. | |
RU2198641C2 (en) | Method for treating ophthalmic diseases | |
Cangelosi et al. | Cataract induction in rabbits with the Nd-YAG laser. | |
RU2120263C1 (en) | Method for carrying out conservative treatment of burned eyes | |
RU2334496C1 (en) | Method of prevention cicatrisation of outflow paths created during anti-glaucoma operation | |
JPH08325143A (en) | Medicine for curing damage of corneal parenchyma | |
SU1474908A1 (en) | Method of treating eye diseases | |
RU2199989C1 (en) | Method for treating retina and optic nerve diseases of dystrophic genesis | |
RU98119433A (en) | METHOD FOR TREATING CORNEAL DISEASES | |
RU2288677C2 (en) | Method for photodynamic therapy of inflammatory diseases in anterior ocular segment | |
SU1602515A1 (en) | Method of treating neovascularization of corneal shell | |
SU1357021A1 (en) | Agent reducing the permeability of capillaries,dicreasing aggregation of thrombocytes and used for treatment of intraocular hemorrhages | |
SU1487902A1 (en) | Method of treating lichorioidal detachments | |
SU1097321A1 (en) | Method of treatment of eye diseases | |
Cassagne et al. | Corneal Collagen Crosslinking Techniques: Updates |